Masimo
MASI
#2119
Rank
A$13.06 B
Marketcap
A$249.50
Share price
0.07%
Change (1 day)
2.77%
Change (1 year)
Masimo is an American manufacturer of noninvasive patient monitoring technologies based in Irvine, California.

P/E ratio for Masimo (MASI)

P/E ratio as of May 2026 (TTM): -59.9

According to Masimo's latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -59.8591. At the end of 2024 the company had a P/E ratio of -29.1.

P/E ratio history for Masimo from 2007 to 2026

PE ratio at the end of each year

Year P/E ratio Change
2024-29.1-138.24%
202376.1
202170.415.39%
202061.042.01%
201943.047.61%
201829.1-11.13%
201732.7193.41%
201611.2-56.18%
201525.5
201328.4

P/E ratio for similar companies or competitors

Company P/E ratio P/E ratio differencediff. Country
Thermo Fisher Scientific
TMO
24.2-140.38%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
34.4-157.52%๐Ÿ‡บ๐Ÿ‡ธ USA
ResMed
RMD
19.5-132.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Cardinal Health
CAH
29.6-149.50%๐Ÿ‡บ๐Ÿ‡ธ USA
UFP Industries
UFPI
17.6-129.32%๐Ÿ‡บ๐Ÿ‡ธ USA
CONMED
CNMD
23.4-139.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Owens & Minor
OMI
-0.1609-99.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Philips
PHG
23.0-138.48%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands

How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share. A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.